The cannabinoids found in plants and cannabis are called phytocannibinoids. Of the 113 cannabinoids, the best known are THC. THC is famous and comes from marijuana. It is well known for it’s psychotropic properties and altered states of consciousness, it has also been credited for it’s interaction with the endocannabinoid system and is effective at treating glaucoma, PTSD and asthma. Hemp is the humble, less-known cousin of marijuana and recently another cannabinoid has been grabbling a lot of attention. CBD, whose psychotropic properties are nearly non-existent and whose benefits on the body is quite impressive. CBD has raised public awareness of both CBD and the medicinal properties of cannabis. The discovery of receptors in the brain that responds to cannabis and the identification of endogenous cannabinoid compounds in our own bodies that bind to these receptors is advancing our understanding of human biology, health and disease.
Naturally, scientists wanted to see if CBD had any anticancer properties. As a result, they performed several animal studies using it. However, it should be noted that the findings don’t fully apply to humans. In fact, they merely suggest what possible effects CBD might have when it comes to dealing with cancer. With that in mind, additional human studies would help conclude if CBD has an effect on cancer cells in humans.
Cannabidiol, or CBD for short, is a natural phyto-cannabinoid (or plant-based chemical compound) found in cannabis plants, including hemp and marijuana. Unlike other cannabinoids — namely tetrahydrocannabinol, or THC — CBD does not produce any psychoactive effects, and will actually counteract these effects to a degree. CBD will induce feelings of sleepiness; for this reason, it can be an effective soporific for people who struggle to fall and/or remain asleep due to insomnia and other sleep disorders.